50 employees
Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer.
2014
$12M
from 2 investors over 2 rounds
Sevion Therapeutics raised $12M on March 29, 2010
Investors: MidOcean Partners and Perceptive Advisors